Japan's Shionogi to make 1 million doses of new Covid-19 treatment by early 2022


  • Japan
  • Wednesday, 29 Sep 2021

The pharmaceutical company plans to submit the drug for regulatory approval in Japan by the end of this year. - AFP

TOKYO (Reuters): Japan's Shionogi & Co Ltd said on Wednesday (Sept 29) it plans to make at least 1 million doses of a new antiviral treatment for Covid-19 for domestic use by March 2022.

The company plans to submit the drug, a protease inhibitor known as S-217622, for regulatory approval in Japan by the end of this year, Chief Executive Isao Teshirogi said at a briefing.

Shionogi started Phase II/III trials of the drug in Japan on Monday. The company is also planning global late-stage trials ahead of filings in the United States and Europe.

The drug can be taken in pill form and is intended for patients in the early stages of Covid-19, compared with antibody treatments that have to be infused by medical staff and are reserved for more serious cases.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Japan , Shionogi , anti-viral , drug

   

Next In Aseanplus News

Asean News Headlines at 10pm on Thursday (Jan 20, 2022)
Singapore's Covid-19 weekly infection growth rate rises to 2.17 - 1,001 new Omicron cases on Thursday (Jan 20)
Philippines logs 31,173 new Covid-19 cases on Thursday (Jan 20); total infections now above 3.3 million
Thailand logs 8,129 Covid-19 cases on Thursday (Jan 20); govt to resume quarantine-free entry for vaccinated visitors from February
Indonesia reports 2,116 new Covid-19 cases and seven more deaths on Thursday (Jan 20)
Vietnam reports 16,715 new Covid-19 cases on Thursday (Jan 20)
Singapore: International school teacher jailed six weeks for assaulting cabby
Thai GDP expected to grow 3.5%-4.5% in 2022 despite Omicron, says finance minister
Indonesia lifts coal export ban on 139 firms as firms met local market sales requirements aimed at averting a supply crunch
Swine fever-hit Philippines sees 'substantial' growth in hog population

Others Also Read


Vouchers